5 Big Companies That Don’t Drug Test Employees

In this article, we discuss 5 big companies that don’t drug test employees. If you want to see our detailed discussion on the topic, check out 25 Big Companies That Don’t Drug Test Employees. 

5. Netflix, Inc. (NASDAQ:NFLX)

Number of Hedge Fund Holders: 108

Netflix, Inc. (NASDAQ:NFLX), like many companies in the technology sector, does not have a drug testing policy for employees. On June 13, BofA reiterated a Buy rating on Netflix, Inc. (NASDAQ:NFLX) and raised its price target on the stock to $490 from $410. BofA noted that Netflix’s password sharing crackdown was faring better than anticipated, and this will support upward Wall Street estimate revisions.

According to Insider Monkey’s first quarter database, 108 hedge funds were bullish on Netflix, Inc. (NASDAQ:NFLX), compared to 117 funds in the prior quarter. Boykin Curry’s Eagle Capital Management is a prominent stakeholder of the company, with 4.26 million shares worth $1.47 billion. 

LVS Advisory made the following comment about Netflix, Inc. (NASDAQ:NFLX) in its Q1 2023 investor letter:

“We initiated our investment in Netflix, Inc. (NASDAQ:NFLX) during the summer of 2022 (discussed in our Q3 2022 letter). Netflix was a baby thrown out with the bath water by the market last year. We found Netflix attractive because the company signaled that it would hold expenses flat while better monetizing its account base via an advertising tier and paid sharing. Despite an impeccable track record of execution, the market didn’t believe Netflix could navigate this transition. While the market now appears to buy into the expense story the market doesn’t fully appreciate the revenue growth story that will play out from the new monetization initiatives. Furthermore, the stock’s pullback during the banking crisis provided an attractive entry point for us to make Netflix an overweight position.”